SCHEMBL20093476

SCHEMBL20093476

Nc1ncnc2[nH]nc(-c3cc(F)c(O)c(F)c3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VRK1 Q99986 1/20 0.41
PIK3CD O00329 17/20 0.38
PIK3CA P42336 16/20 0.38
PIK3CB P42338 16/20 0.38
PIK3CG P48736 16/20 0.38
PRKDC P78527 16/20 0.38
MTOR P42345 14/20 0.38
ABL1 P00519 13/20 0.38
EGFR P00533 13/20 0.38
HCK P08631 13/20 0.38
SRC P12931 13/20 0.38
KDR P35968 13/20 0.38
EPHB4 P54760 12/20 0.38
PI4KB Q9UBF8 9/20 0.38
BTK Q06187 1/20 0.35
SGK1 O00141 1/20 0.35
MEN1 O00255 1/20 0.35
DYRK3 O43781 1/20 0.35
EIF4E P06730 1/20 0.35
EIF2AK2 P19525 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16655157 0.87 PIK3CD (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL9010 0.85 PIK3CG (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917192 0.84 MAP4K4 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16065725 0.83 PIK3CD (0.53) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11975 0.82 PIK3CB (0.39) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11928101 0.82 PIK3CD (0.56) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16665741 0.78 PIK3CD (0.36) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11325 0.77 PIK3CG (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20793723 0.77 FAAH (0.40) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16665713 0.77 PIK3CD (0.36) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858907-B2 Kinase modulators RHIZEN PHARMACEUTICALS AG (CH) 2024-01-02 US disclosed
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-10-15 US disclosed
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases PIK3CB, PIK3CD, PDPK1 VRK1 341/4885PIK3CD 2/4885PIK3CA 4/4885
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B VRK1 265/4885PIK3CD 89/4885PIK3CA 106/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB VRK1 283/4885PIK3CD 47/4885PIK3CA 88/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 VRK1 485/4885PIK3CD 148/4885PIK3CA 153/4885
US-11858907-B2 Kinase modulators RPS6KA1, RPS6KA2, PRKAR2A VRK1 628/4885PIK3CD 103/4885PIK3CA 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.